Linked Life Data

17530476

Source:http://linkedlifedata.com/resource/pubmed/id/17530476

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-8-16
pubmed:abstractText
Paliperidone (9-OH-risperidone) is the main metabolite of the atypical antipsychotic risperidone. While both drugs are potent dopamine (D)2 antagonists, they have quantitative differential affinities for serotonin (5-HT) and norepinephrine (NE) receptor binding sites.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/9-hydroxy-risperidone, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Citalopram, http://linkedlifedata.com/resource/pubmed/chemical/Desipramine, http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Risperidone, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT1 Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/WAY 100635
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0033-3158
pubmed:author
pubmed:issnType
Print
pubmed:volume
194
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-72
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17530476-Adrenergic Uptake Inhibitors, pubmed-meshheading:17530476-Animals, pubmed-meshheading:17530476-Antipsychotic Agents, pubmed-meshheading:17530476-Citalopram, pubmed-meshheading:17530476-Desipramine, pubmed-meshheading:17530476-Dose-Response Relationship, Drug, pubmed-meshheading:17530476-Electrophysiology, pubmed-meshheading:17530476-Infusion Pumps, pubmed-meshheading:17530476-Injections, Intravenous, pubmed-meshheading:17530476-Isoxazoles, pubmed-meshheading:17530476-Male, pubmed-meshheading:17530476-Neurons, pubmed-meshheading:17530476-Norepinephrine, pubmed-meshheading:17530476-Piperazines, pubmed-meshheading:17530476-Pyridines, pubmed-meshheading:17530476-Pyrimidines, pubmed-meshheading:17530476-Rats, pubmed-meshheading:17530476-Rats, Sprague-Dawley, pubmed-meshheading:17530476-Risperidone, pubmed-meshheading:17530476-Serotonin, pubmed-meshheading:17530476-Serotonin 5-HT1 Receptor Antagonists, pubmed-meshheading:17530476-Serotonin Antagonists
pubmed:year
2007
pubmed:articleTitle
Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
pubmed:affiliation
University of Ottawa Institute of Mental Health Research, 1145 Carling Avenue Suite 6419, Ottawa, ON K1Z-7K4, Canada. edremenc@rohcg.on.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't